Advancement into the Arctic Region for Bioactive Sponge Secondary Metabolites by Abbas, Samuel et al.
Mar. Drugs 2011, 9, 2423-2437; doi:10.3390/md9112423 
 
Marine Drugs  
ISSN 1660-3397 
www.mdpi.com/journal/marinedrugs 
Review 
Advancement into the Arctic Region for Bioactive Sponge 
Secondary Metabolites 
Samuel Abbas 
1, Michelle Kelly 
2, John Bowling 
1, James Sims 
1, Amanda Waters 
1 and  
Mark Hamann 
1,* 
1  Department of Pharmacognosy, School of Pharmacy, University of Mississippi, MS 38677, USA; 
E-Mails: shabbas@olemiss.edu (S.A.); jjbowlin@olemiss.edu (J.B.); jwsims@olemiss.edu (J.S.); 
alwaters@olemiss.edu (A.W.) 
2  National Centre for Aquatic Biodiversity and Biosecurity, National Institute of Water and 
Atmospheric Research Ltd., Auckland Central 1149, New Zealand;  
E-Mail: m.kelly@niwa.co.nz  
*  Author to whom correspondence should be addressed; E-Mail: mthamann@olemiss.edu;  
Tel.: +1-662-915-5730; Fax: +1-662-915-6975. 
Received: 22 September 2011; in revised form: 9 November 2011 / Accepted: 11 November 2011 / 
Published: 21 November 2011 
 
Abstract: Porifera have long been a reservoir for the discovery of bioactive compounds 
and drug discovery. Most research in the area has focused on sponges from tropical and 
temperate waters, but more recently the focus has shifted to the less accessible colder 
waters of the Antarctic and, to a lesser extent, the Arctic. The Antarctic region in particular 
has been a more popular location for natural products discovery and has provided promising 
candidates for drug development. This article reviews groups of bioactive compounds that 
have been isolated and reported from the southern reaches of the Arctic Circle, surveys the 
known sponge diversity present in the Arctic waters, and details a recent sponge collection 
by  our  group  in  the  Aleutian  Islands,  Alaska.  The  collection  has  yielded  previously 
undescribed sponge species along with primary activity against opportunistic infectious 
diseases, malaria, and HCV. The discovery of new sponge species and bioactive crude 
extracts gives optimism for the isolation of new bioactive compounds from a relatively 
unexplored source.  
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1. Introduction 
Marine sponges have provided a vast resource in the search for bioactive secondary metabolites and 
potential drug leads. With most research in the area of bioactive sponge metabolites being conducted 
in  temperate  and  tropical  areas  and  the  strong  emergence  of  a  myriad  of  disease  resistance,  it  is 
becoming increasingly important to survey the fauna of remote regions of the globe for new and 
replacement  drug  therapies  or  compounds  with other useful bioactivities. Porifera of cold  water 
environments, including the deep sea and northern polar regions in particular, are marginally known in 
terms of their faunas, and as such are a relatively untapped resource for scientific discovery. In fact, of 
all marine natural products described, less than 3% originate from organisms in polar environments [1]. 
Among  the  research  conducted  in  polar  environments,  the  majority  of  compounds  isolated  and 
characterized have come from the Antarctic region [1,2]. This article discusses bioactive molecules 
that have been discovered in the southern reaches of the Arctic Circle and the particular significance of 
a recent sponge collection conducted in the Aleutian Islands, Alaska. The handful of studies that have 
been completed in this area are primarily represented by sponges collected in more easily accessible 
coastal waters of Alaska and off the coast of Sweden and Norway. A potentially fruitful opportunity 
for new bioactive marine secondary metabolites lies within the cold water regions of the earth, where 
little, but promising, research has been completed.  
Articles  addressing  cold  water  bioactive  metabolites  and  the  chemical  ecology  of  cold  water 
sponges, particularly the Antarctic region, have been published by our group and others [1–4]. These 
articles cover some of the compounds listed here and should be consulted for a thorough recording of 
cold water marine metabolites from various organisms. This work focuses mainly on bioactive sponge 
metabolites from Alaska and other more northern Arctic cold water regions. 
2. Secondary Metabolites from Polar Sponges  
There are many reasons for the lack of exploration of the metabolites of polar sponges, but the most 
obvious  are  the  difficulties associated with the access  to  polar  regions  and  the  harsh  working 
environments.  Several  decades  ago  the  misconception  was  held  that,  due  to  the  harshness  of  the 
general environment, sponge biodiversity in polar regions would be poor, and competitive pressure to 
develop chemical defenses were low or non-existent [1]. However, today we know from work in the 
Antarctic and revised opinions of Arctic benthos that polar regions are rich in sponge diversity [5–7] 
with  comparable  species  numbers  to  southern  cold-temperate  regions  [8]  and  that  polar  marine 
invertebrates,  including  sponges,  possess  a  high  number  of  chemical  defenses  [9].  Despite  the 
suggestions of high polar sponge biodiversity and thus a potential source for marine drug discovery, 
less than 100 metabolites from cold water sponges have been described as of 2010, as compared to 
thousands from temperate and tropical regions [10]. Consequently, extensive sponge surveys in the 
polar environments for the discovery of new bioactive molecules have merit. The following information 
reviews the bioactive compounds that have been discovered from marine sponges collected in the 
southern-most limits of the Arctic Ocean. 
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2.1. Discorhabdin Alkaloids 
One  of  the  major  groups  of  compounds  that  have  been  found  in  polar  sponges  of  the  genus 
Latrunculia (Class Demospongiae, Order Poecilosclerida, Family Latrunculiidae) are the discorhabdin 
alkaloids. Many different derivatives of discorhabdins were originally isolated from Antarctic and New 
Zealand species of Latrunculia yielding an impressive array of activities. Discorhabdin C (1) (Figure 1) 
was first described in 1986 as isolated from the New Zealand species L. cf bocagei Ridley and Dendy, 
1886, and exhibited potent antitumor bioactivity against L1210 tumor cells with an ED50 of less than 
100 ng/mL [11]. Discorhabdin F [12] was subsequently isolated in 1990 from the Antarctic species  
L.  biformis  Kirkpatrick, 1907 followed by Discorhabdin G from L.  apicalis  Ridley and Dendy,   
1886 [13,14]. Discorhabdin R (2) (Figure 1) was isolated in 2000 from an unidentified species of 
Latrunculia collected from Prydz Bay, Antarctica, exhibiting activity similar to other discorhabdins 
encompassing Gram positive and Gram negative species of bacteria among others [15].  
Figure  1.  Discorhabdin C (1) and Discorhabdin R (2); members of the discorhabdin 
alkaloids, exhibiting a spectrum of bioactivities, isolated in 1986 and 2000, respectively, 
from New Zealand and Antarctic sponge species of the genus Latrunculia [11,15]. 
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In  2009,  eight  members  of  the  same  class  of  discorhabdin  alkaloids,  including  the  two  new 
molecules  dihydrodiscorhabdin  B  (3)  and  discorhabdin  Y  (4),  were  isolated  from  members  of 
Latrunculia in the Arctic region off the coast of Alaska in the Aleutian Islands (Figure 2) [4]. This was 
the first report of bioactive compounds from sponges collected in the Alaskan region. The compounds 
isolated from this new, undescribed species of Latrunculia, demonstrated anti-HCV, antimalarial, and 
antibacterial activities along with two previously described discorhabdins, dihydrodiscorhabdin C (5) 
and  discorhabdin  A  (6), showing selective anti-protozoal  activity  in  vitro  [4].  From  this  report, 
compounds 5 and 6, along with compound 1, had reported IC50 values of 170, 53, and 2800 nM  
against  chloroquine-susceptible  Plasmodium  falciparum  and  130,  53,  and  2000  nM  against  
chloroquine-resistant P. falciparum, respectively. Compounds 5 and 6 were tested in vivo using a 
murine model for antimalarial activity however high levels of toxicity were observed including weight 
loss, movement reduction, and dehydration. Regardless of these in vivo results, the first report of 
bioactive compounds from an Alaskan sponge being used in an animal model provides promise for 
future  bioactive  molecules  from  the  region.  Reports  suggest  that  the  discorhabdin  alkaloids  have 
potential due to their varied biological activities, and new information on the group and the species 
they have been isolated from [16–19] have been discovered during the past 25 years. Mar. Drugs 2011, 9                  
 
 
2426 
Figure 2. Compounds isolated from a new, undescribed species of Latrunculia from the 
Aleutian  Islands.  The compounds listed are dihydrodiscorhabdin  B  (configuration 
unassigned)  (3),  discorhabdin  Y  (4),  dihydrodiscorhabdin  C  (5),  discorhabdin  A  (6), 
discorhabdin E (7), discorhabdin L (8), and also discorhabdin C (1, Figure 1) [4].  
 
2.2. Monanchocidins 
A group of new polycyclic guanidine containing alkaloids were discovered from Monanchora 
pulchra in 2010 and 2011 [20,21] near Urup Island in the southern Sea of Okhotsk at a similar latitude 
to the discorhabdins in Figure 2. Monanchocidin A–E (9–13)  (Figure 3) demonstrated  
apoptosis-inducing activity against HL-60 human leukemia cells with 540, 200, 110, 830, and 650 nM 
respectively [21].  
Figure 3. Cytotoxic Monanchocidins A–E (9–13) isolated from M. pulchra [21].  
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2.3. 3-Alkyl Pyridinium Alkaloids 
A  series  of  3-alkyl  pyridinium  alkaloids  have  been  isolated  from  the  Arctic  sponge  Haliclona 
(Rhizoniera) viscosa (Topsent, 1888) (Class Demospongiae, Order Haplosclerida, Family Chalinidae) 
with  interesting  bioactivity  including  antibacterial,  antifungal,  cytotoxic,  and  feeding  deterrent  
effects [22]. Until 2004 Haliclona spp. and related genera had only been described from more tropical 
and temperate environments where they are more abundant and diverse in terms of species. Specimens 
of H. viscosa were collected in Kongsfjorden, an inlet on the west coast of Spitsbergen, an island 
which is part of the Svalbard Archipelago in the Arctic Ocean. The specimens yielded 2 compounds 
elucidated as viscosamine (14) and viscosaline (15)  (Figure 4), the first acyclic dimeric 3-alkyl 
pyridinium alkaloid isolated from nature [23]. Both compounds exhibit antibacterial activity while 
viscosaline has been reported as a feeding deterrent against the amphipod Anonyx nugax  and  
starfish [22]. 
Figure 4. Bioactive compounds viscosamine (14) and viscosaline (15) isolated from Arctic 
sponge Haliclona viscosa [23]. 
 
2.4. Diketopiperazines 
Two diketopiperazines, barettin (16)  (Figure 5)  and 8,9-dihydrobarettin were isolated from the 
sponge  Geodia barretti  Bowerbank, 1858 (Class Demospongiae, Order Astrophorida, Family 
Geodiidae) in the North Sea off the coast of Sweden [24]. These compounds  exhibited extremely 
interesting non-toxic bioactivity  as  an  antifouling  agent,  inhibiting  the  settlement  of  larvae  of  the 
barnacle Balanus improvisus and the blue mussel Mytilus edulis when mixed with surface coatings. 
Figure 5.  Barettin (16),  isolated  from the sponge  Geodia barretti collected in the   
North Sea [24]. 
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2.5. Polymastiamides 
Polymastiamide A (17) (Figure 6), the first reported marine natural product derived from a steroid 
and  α-amino acid component, was isolated from the Norwegian sponge Polymastia boletiformis 
(Lamarck, 1815) (Class Demospongiae, Order Hadromerida, Family Polymastiidae), and showed  
in vitro activity against micro-organisms S. aureus, C. albicans, and P. ultimum [25]. Conjugates with 
similar steroid/amino acid conformations were subsequently isolated from the same sponge species to 
give polymastiamides B (18), C (20), D (21), E (19), and F (22) [24] (Figure 6). 
Figure 6. Polymastiamide A, B, E (17, 18, 19) and C, D, F (20, 21, 22) isolated from the 
Norwegian sponge Polymastia boletiformis [25,26]. 
 
2.6. Cyclic Peroxides 
Another  Norwegian  sponge,  Plakortis  simplex  Schulze, 1880 (Class Demospongiae, Order 
Homosclerophorida, Family Plakinidae), yielded two new cyclic peroxides (23, 24) (Figure 7) with 24 
showing in vitro IC50 values between 7 and 15 µg/mL for a number of different solid human tumor cell 
lines [27]. 
Figure 7.  Two cyclic peroxides, 23  and  24, isolated from the Norwegian sponge   
Plakortis simplex [27]. 
 
3. Recent Collections Around the Aleutian Islands, Alaska 
Two recent collection trips were performed in collaboration with the NOAA/AFSC annual groundfish 
survey. Collections sites in the summer of 2010 were in the western Aleutian Islands between Adak 
Island and Stalemate Bank. The depths of these collections ranged 60–400 m. Specimens were 
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collected by fishing trawl and were sorted by morphology and immediately frozen at −20 °C. Following 
the survey samples were shipped frozen for extraction and chemical analysis. 
3.1. New Arctic Sponges 
Our understanding of the sponge fauna of the Aleutian Islands and the Alaskan Arctic is aided by 
taxonomic literature based on collections principally from the Chukchi and East Siberian Seas, the 
Aleutian Island chain and Alaskan coastline to the north, Kamchatka Peninsula, Kurile Islands, the Sea 
of Okhotsk to the west, and the Bering Sea to the north. Unfortunately, unlike the Antarctic region, few 
large scale collections and taxonomic studies of the overall sponge fauna of this region have been 
produced [28], and many works are very old and in need of revision. Unfortunately, a full review of 
the species known from the region has not been possible, but we know from recent studies [29,30] and 
collections that the sponge demosponge fauna, at least, is diverse and dominated by poecilosclerid taxa.  
General literature for the Bering Sea and Alaskan Arctic includes [31–34] for the southwestern Sea 
of Okhotsk and [35] for the northwest Pacific in general. More recently, Lehnert et al. [28] (and in 
previous works), commenced the documentation of a number of deep and shallow water sponges from 
the region, many of which were found to be new species. Taxonomic literature from the Gulf of Alaska 
and  British  Columbia  to  the  southeast  of  the  Aleutians,  and  to  a  lesser  extent,  the  coasts  of 
Washington, Oregon and northern California, are important resources for any work in the Aleutians 
and Alaskan Arctic. Lambe [36–38], more recently Austin [29], and Austin and Ott [30] provide the 
best starting points for any taxonomic work in the region. Lee et al. [39] on the sponges of California 
is also particularly relevant.  
Of the 93 sponge specimens collected during the 2010 voyage, 6 have been formally identified and 
two are new, undescribed species. Five out of the 6 specimens are in the Order Poecilosclerida, the 
most diverse order of demosponges, and typically the most common type of demosponge found in 
polar regions [6]. The sixth specimen is from the Order Astrophorida, an order of Demospongiae much 
less common in polar regions than in temperate regions such as around New Zealand [6,8].  
Of  the  5  poecilosclerid  sponges,  two  were  species  of  Latrunculia  (Family  Latrunculiidae);  
L. oparinae Samaai and Krasokhin, 2002, and the new species detailed in [4]. This genus has presented 
a major group of compounds, the discorhabdin alkaloids, with a striking array of activities as detailed 
above. Research on this important group has focused on Antarctic and New Zealand species, but we 
are now documenting their existence in the North Pacific and southern Arctic regions [11–15]. Prior to 
this work, L. oparinae  was known only from the Russian Kurile Islands, in the Sea of Okhotsk, 
between 127 and 238 m. In the Aleutian Islands, the species is quite common where it is found 
between 81 and 288 m. The species has a globular shape with tall cylindrical oscules (exhalent 
structures), and is light olive to khaki green in life. The new, and as yet, undescribed species detailed 
in [4] is similar to L. oparinae but differentiated by color in life. It is dark purple brown, possesses the 
short flat oscules, and the perfectly hemispherical shape. L. austini Samaai, Gibbons and Kelly, 2006, 
known from the Vancouver Coast of British Columbia, Canada, and further south, is a relatively 
shallow water species (20–50 m), grayish brown in life, spherical in shape, and with broad crater-like 
areolate porefields that dominate the sponge surface. Latrunculia velera Lehnert, Stone and Heimler, 
2006, from the Aleutian Islands, is a dark brown elongate to subglobose sponge with short tiny Mar. Drugs 2011, 9                  
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oscules. The primary feature that differentiates each of these species is the shape and ornamentation of 
the family-specific microsclere, the anisodiscorhabd (Figure 8. L. occulta Lehnert, Stone and Heimler, 
2006, also from the Aleutian Islands, is now considered to be a species of the genus Chondrocladia 
(Meliiderma) (Order Poecilosclerida, Family Cladorhizidae) [40].  While these species produce an 
array of different compounds, they are difficult to differentiate at the species level other than by the 
shape and ornamentation of the family-specific microsclere, the anisodiscorhabd (Figure 8). 
Figure 8. Comparison of the morphology and ornamentation of anisodiscorhabd spicules 
that  distinguish  species  of  Latrunculia  in  the  northern  Pacific-Arctic  region:  
(a) Latrunculia oparinae Samaai and Krasokhin, 2002; (b) Latrunculia n. sp. (dark purple 
brown  hemisphere);  (c)  Latrunculia  austini  Samaai,  Gibbons  and  Kelly,  2006;  
(d) Latrunculia velera Lehnert, Stone and Heimler, 2006; (e) Latrunculia occulta Lehnert, 
Stone and Heimler, 2006; Scale bar = 10 µm. 
 
Of  the  5  poecilosclerid  sponges,  two  were  species  of  Monanchora  (Family  Crambeidae);  
M. pulchra (Lambe, 1895), first described from the Aleutian Islands, and a new, undescribed species, 
M. n. sp. 1 (yellow fan). There are two additional species of this genus known from the Aleutian 
Islands, Eastern Bering Sea, and the Gulf of Alaska; M. alaskensis (Lambe, 1895) and M. laminachela 
(Lehnert, Stone, and Heimler, 2006). The key differences between these 4 species are in the gross 
morphology of the sponge, the coloration life, the length of the skeleton-forming megascleres, and the 
length and shape of the microscleres (Table 1).  
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Table 1. Key differences between species of Monanchora (Order Poecilosclerida, Family 
Crambeidae) in the Aleutians-Arctic region. 
 
Monanchora 
pulchra 
Monanchora n. sp. 
1 (yellow fan) 
Monanchora 
alaskensis 
Monanchora 
laminachela 
shape  ramose fan  fan  short flabby  subglobular 
color in life  red  yellow  brown  yellow 
styles (interior) (µm)  1100  480–510  262  840–1170 
styles (dermal) (µm)  176–478  200–250  144  350–395 
microscleres 1 (µm)  19  30–35  91  22–25 
microscleres 2 (µm)  13  20  32  19–23 
A new undescribed species of Guitarra (Order Poecilosclerida, Family Guitarridae) was amongst 
the 6 poecilosclerid sponges identified and has been analyzed in greater detail than the other 4 species. 
The specimen was dredged from a depth of 94 m from the Aleutian Islands, where it was moderately 
common. In life the sponge forms a massive encrustation with deep cracks outlining polygonal 
“plates”. The texture is tough, the color in life is peach to orange-yellow. The sponge is characterized 
by very long megascleres (oxeas 580–600 µm long) and three forms of microscleres (biplacochelae, c. 
47 µm long, in addition to the usual placochelae, c. 47 µm long, and small, spiny bipocillae and 
anisobipocillae, c. 15 µm long). The most closely comparable species to Guitarra n. sp. is G. abbotti 
Lee, 1987, from Cordell Bank, northern California. Guitarra abbotti also has the unusual biplacochelae 
in addition to the usual oxeas, placochelae, and bipocillae microscleres, but these differ considerably in 
length from those in Guitarra n. sp. The oxeas of G. abbotti are half the length (330 µm) of those in 
Guitarra n. sp., and there are two sizes of placochelae in the former species, the larger of which is 
twice the length of those in Guitarra n. sp. (83 µm long) with the smaller size being 37 µm long. The 
biplacochelae of G. abbotti are slightly smaller (36 µm) than those in Guitarra n. sp, and the bipocillae 
are half the length (7 µm) of those in the new species. 
The single astrophorid species is Poecillastra rickettsi de Laubenfels, 1930 (Family Pachastrellidae), 
first described from northern California. 
3.2. Isolation and Elucidation Efforts 
Each of the 93 sponge samples were initially processed by extracting 50 g portions (wet) with 
ethanol. The resulting extract was submitted for opportunistic infections, antimalarial, and antiHCV 
assays. For more rapid results, each extract was screened using a disc diffusion assay against B. cereus. 
Extracts were tested at 1 mg/mL concentrations with kanamycin used as a positive control. 
The new species of Guitarra was examined because of initial activity from the disc diffusion assay 
against B. cereus. The complete 1 kg (wet wt.) specimen was extracted with ethyl acetate to yield 11 g. 
The resulting extract was subject to a silica flash column and the activity eluted from a fraction of 1:1 
hexane  and  ethyl  acetate.  The  resulting  fraction  (483  mg) was subject to separation using 3 cm 
diameter LH20 column and a 1:1 mixture of dichloromethane and methanol. The activity was traced to 
a group of fractions that were combined then subjected to further separation on a Waters Delta HPLC 
system equipped with an analytical scale UV detector set to 280 nm and using a 4.6 × 150 mm 
Phenomenex Luna Silica column eluted with a linear gradient from 100% pentane to 100% Mar. Drugs 2011, 9                  
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dichloromethane over 75 min. The HPLC separation yielded sub-miligram amounts  of two pure 
compounds that were identified as 4-hydroxybenzaldehyde  and  indole-3-carboxaldehyde  based  on 
comparison of standards with 
1H NMR and GC-MS results (supplemental information). 
3.3. Bioactivity 
An initial  in  vitro  screen of 93 crude sponge extracts revealed  bioactivity  against  many 
microorganisms associated with opportunistic infections (Figure 9), indicating a broader than expected 
activity  against  a  small  sample  set  of  different  microorganisms.  The  extracts  were  also  screened 
against Plasmodium falciparum (malaria) and HCV resulting in the identification of several samples 
with significant activity. 
Figure  9.  The  percent  of  crude  extracts  of  93  Alaskan  sponge  samples  that  yielded 
significant activity (greater than 50% inhibition in vitro) against different opportunistic 
infections (Candida albicans, Candida glabrata, Candida krusei, Aspergillus fumigatus, 
Cryptococcus  neoformans,  Staphylococcus  aureus,  Methicillin-resistant  Staphylococcus 
aureus,  Escherichia  coli,  Pseudomonas  aeruginosa), malaria, and hepatitis C virus 
(HCV)(methods described in [4]). 
 
The IC50 values for active sponge extracts ranged from 200 to 5000 ng/mL against the different 
opportunistic infections (ciprofloxacin and amphotericin B as controls) and antimalarial IC50 ranged 
between 500 and 2200 ng/mL (chloroquine and artemisinin as controls); anti-HCV IC50 values were 
not determined. Many of the active samples are currently being examined for their active components 
and will be reported in due time. The initial screen for activity combined with the evidence of interesting 
taxonomic classification highlights the potential of the polar region for new bioactive compounds.  
Antibacterial activity for Bacillus cereus guided the isolation and lead to the elucidation of two 
known aldehydes mentioned previously identified from the new sponge species of the genus Guitarra. 
Indole-3-carboxaldehyde  was  isolated  previously  from  marine  Pseudomonas  species  [41].  Using 
purchased standards of these molecules, the original bioactivity of the crude extract was unable to be 
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reproduced. In spite of this result, 4-hydroxybenzaldehyde has been reported as active against some 
bacterial and yeast species [42]. Interestingly, it has also been isolated from a perennial saprophytic 
herb Gastrodia elata and demonstrated unique bioactivity. Assays performed in vivo using rats proved 
to give 4-hydroxybenzaldehyde anticonvulsive and antiepileptic properties [43]. 
4. Conclusions  
With roughly 70% of the earth covered with ocean, marine sources provide an enormous source for 
scientific research and discovery. Numerous collections conducted for over half a century to collect 
sponges in particular for their bioactive secondary metabolites have been carried out in many cold 
temperate, temperate, tropical, and subtropical locations across the Atlantic and Pacific Oceans and in 
other parts of the globe. These efforts and their results are thoroughly described in a series of reviews [44]. 
By contrast, dedicated collections of sponges to specifically isolate and characterize metabolites from 
sponges in the Arctic and Alaskan regions have been few and far between as illustrated in Figure 10, 
and yet the biodiversity of the Gulf of Alaska and British Columbia in particular, is known to be 
considerable. The discovery of new species with diverse bioactivity as indicated by the initial screen of 
the 2010 collection of Aleutian sponges and previous collections made by our group in the general area 
bodes well for the future of new and valuable bioactive compounds. 
Figure 10. A view of the earth directly over the North Pole which indicates the collection 
sites that yielded the bioactive metabolites presented in this review. The following image 
was created using Google Earth (version 6.1.0.5001). 
 
 
A.  Discorhabdins (3-8); Aleutian 
Islands collection 
B.  Monanchocidins (9-13) 
C.  Pyridinium alkaloids (14,15) 
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